An Open-label Study That Will Test a Second Treatment Session of RZL-012.
Clinical trial NCT05763160 · COMPLETED
Trial details
- NCT number
- NCT05763160
- Sponsor
- Raziel Therapeutics Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-29
- Primary completion
- 2023-07-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.